Find Grants for Non-profits

Find Out If You Qualify for Verified Grants! Discover your eligibility and access 1,903 verified grants for nonprofits, small businesses, startups, and individuals from trusted foundations and government sources.

Total Dollar Available
$ 100 Trillion

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

Deadline: October 15, 2027

Opportunity Number: PAR-25-183

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

View Grant

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

Deadline: October 15, 2027

Opportunity Number: PAR-25-184

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

View Grant

Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)

Deadline: October 15, 2027

Opportunity Number: PAR-25-285

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

View Grant

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Deadline: October 15, 2027

Opportunity Number: PAR-25-180

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

View Grant

Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)

Deadline: October 15, 2027

Opportunity Number: PAR-25-177

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

View Grant

Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)

Deadline: October 15, 2027

Opportunity Number: PAR-25-178

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

View Grant

HIV Prevention and Alcohol (R01 Clinical Trials Optional)

Deadline: May 7, 2026

Opportunity Number: PAS-25-208

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.273

View Grant

HIV Prevention and Alcohol (R34 Clinical Trials Optional)

Deadline: May 7, 2026

Opportunity Number: PAS-25-161

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.273

View Grant

Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R01 Clinical Trial Required)

Deadline: January 7, 2028

Opportunity Number: PAR-25-289

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242

View Grant

Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required)

Deadline: January 7, 2028

Opportunity Number: PAR-25-288

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242

View Grant

New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)

Deadline: May 7, 2027

Opportunity Number: PAR-25-279

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: May 7, 2027

Status: Posted

CFDA Numbers: 93.396, 93.866, 93.865, 93.286

View Grant

New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)

Deadline: May 7, 2027

Opportunity Number: PAR-25-272

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: May 7, 2027

Status: Posted

CFDA Numbers: 93.866, 93.396, 93.865

View Grant

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)

Deadline: January 7, 2027

Opportunity Number: PAR-25-159

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.273

View Grant

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

Deadline: November 17, 2026

Opportunity Number: PAR-25-158

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: November 17, 2026

Status: Posted

CFDA Numbers: 93.273

View Grant

The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)

Deadline: January 7, 2028

Opportunity Number: PAR-25-292

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.866, 93.361, 93.393, 93.307, 93.399, 93.396, 93.279, 93.242

View Grant

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

Deadline: December 23, 2027

Opportunity Number: RFA-HL-26-019

Agency: National Institutes of Health

Open Date: November 22, 2024

Close Date: December 23, 2027

Status: Posted

CFDA Numbers: 93.837, 93.233, 93.839, 93.838

View Grant

Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

Deadline: December 23, 2027

Opportunity Number: RFA-HL-26-016

Agency: National Institutes of Health

Open Date: November 22, 2024

Close Date: December 23, 2027

Status: Posted

CFDA Numbers: 93.839, 93.233, 93.838, 93.837

View Grant

Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)

Deadline: December 23, 2027

Opportunity Number: RFA-HL-26-020

Agency: National Institutes of Health

Open Date: November 22, 2024

Close Date: December 23, 2027

Status: Posted

CFDA Numbers: 93.839, 93.233, 93.837, 93.838

View Grant

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

Deadline: December 23, 2027

Opportunity Number: RFA-HL-26-017

Agency: National Institutes of Health

Open Date: November 22, 2024

Close Date: December 23, 2027

Status: Posted

CFDA Numbers: 93.839, 93.838, 93.233, 93.837

View Grant

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

Deadline: December 23, 2027

Opportunity Number: RFA-HL-26-018

Agency: National Institutes of Health

Open Date: November 22, 2024

Close Date: December 23, 2027

Status: Posted

CFDA Numbers: 93.839, 93.233, 93.838, 93.837

View Grant

Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)

Deadline: January 7, 2028

Opportunity Number: PAR-25-281

Agency: National Institutes of Health

Open Date: November 22, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242, 93.313

View Grant

Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)

Deadline: January 7, 2028

Opportunity Number: PAR-25-282

Agency: National Institutes of Health

Open Date: November 22, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242, 93.313

View Grant

Occupational Safety and Health Training Project Grants (T03)

Deadline: October 26, 2028

Opportunity Number: RFA-OH-25-003

Agency: Centers for Disease Control and Prevention - ERA

Open Date: November 22, 2024

Close Date: October 26, 2028

Status: Posted

CFDA Numbers: 93.262

View Grant

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

Deadline: November 19, 2026

Opportunity Number: PAR-25-226

Agency: National Institutes of Health

Open Date: November 22, 2024

Close Date: November 19, 2026

Status: Posted

CFDA Numbers: 93.242

View Grant

Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)

Deadline: January 7, 2028

Opportunity Number: PAR-25-290

Agency: National Institutes of Health

Open Date: November 22, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242

View Grant